Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E I Shmelev

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Terapevticheskii Arkhiv|October 22, 2013
[Stepwise treatment in patients with isolated thermal inhalation injury]S A Degtiareva, E I Shmelev, S V Smirnov, et al.
Vestnik Rentgenologii I Radiologii|August 10, 2000
[Radiation diagnosis of interstitial lung diseases]L I Dmitrieva, E I Shmelev, I E Stepanian, et al.
Problemy Tuberkuleza I Boleznei Legkikh|April 23, 2009
[Nonspecific lung diseases in patients with pulmonary tuberculosis (issues of their prevalence, diagnosis and treatment)]G M Kuklina, M A Iakimova, V V Punga, et al.
Problemy Tuberkuleza I Boleznei Legkikh|December 1, 2004
[Use of dissolved ozone in the treatment of experimental tuberculosis in mice]I I Belianin, E I Shmelev, L P Martynova, et al.
Problemy Tuberkuleza I Boleznei Legkikh|September 28, 2006
[Clarythromycin in the treatment of exacerbations of chronic obstructive lung disease]E I Shmelev, A E Ergeshev, N M Shmeleva, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|June 1, 1990
[An analysis of the dysentery epidemic process in Blagoveshchensk]V K Kurganov, V V Krasnikov, O P Pischikova, et al.
Problemy Tuberkuleza I Boleznei Legkikh|December 30, 2008
[Possibilities of improving the diagnosis and treatment of obstructive pulmonary diseases in the Northern Administrative District of Moscow]N M Shmeleva, I V Galkin, V P Sidorova, et al.
Terapevticheskii Arkhiv|January 1, 1991
[Use of plasmacytapheresis in combined modality therapy of patients with fibrosing alveolitis]A G Khomenko, E I Shmelev, I E Stepanian, et al.
Problemy Tuberkuleza I Boleznei Legkikh|August 5, 2005
[The hemostatic system and correction of its impairments, by using the disaggregatory agent ticlopidine and low-molecular-weight heparin in patients with idiopathic fibrosing alveolitis]S N Vasil'ev, I E Stepanian, G O Kaminskaia, et al.
Terapevticheskii Arkhiv|May 11, 2023
Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseasesE I Shchepikhin, E I Shmelev, A E Ergeshov, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Terapevticheskii Arkhiv|October 22, 2013
[Stepwise treatment in patients with isolated thermal inhalation injury]S A Degtiareva, E I Shmelev, S V Smirnov, et al.
Vestnik Rentgenologii I Radiologii|August 10, 2000
[Radiation diagnosis of interstitial lung diseases]L I Dmitrieva, E I Shmelev, I E Stepanian, et al.
Problemy Tuberkuleza I Boleznei Legkikh|April 23, 2009
[Nonspecific lung diseases in patients with pulmonary tuberculosis (issues of their prevalence, diagnosis and treatment)]G M Kuklina, M A Iakimova, V V Punga, et al.
Problemy Tuberkuleza I Boleznei Legkikh|December 1, 2004
[Use of dissolved ozone in the treatment of experimental tuberculosis in mice]I I Belianin, E I Shmelev, L P Martynova, et al.
Problemy Tuberkuleza I Boleznei Legkikh|September 28, 2006
[Clarythromycin in the treatment of exacerbations of chronic obstructive lung disease]E I Shmelev, A E Ergeshev, N M Shmeleva, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|June 1, 1990
[An analysis of the dysentery epidemic process in Blagoveshchensk]V K Kurganov, V V Krasnikov, O P Pischikova, et al.
Problemy Tuberkuleza I Boleznei Legkikh|December 30, 2008
[Possibilities of improving the diagnosis and treatment of obstructive pulmonary diseases in the Northern Administrative District of Moscow]N M Shmeleva, I V Galkin, V P Sidorova, et al.
Terapevticheskii Arkhiv|January 1, 1991
[Use of plasmacytapheresis in combined modality therapy of patients with fibrosing alveolitis]A G Khomenko, E I Shmelev, I E Stepanian, et al.
Problemy Tuberkuleza I Boleznei Legkikh|August 5, 2005
[The hemostatic system and correction of its impairments, by using the disaggregatory agent ticlopidine and low-molecular-weight heparin in patients with idiopathic fibrosing alveolitis]S N Vasil'ev, I E Stepanian, G O Kaminskaia, et al.
Terapevticheskii Arkhiv|May 11, 2023
Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseasesE I Shchepikhin, E I Shmelev, A E Ergeshov, et al.
Pageof 6